Inhibition of microglia activation affected the maintenance of cancer pain in a murine model

Yuan-zhang TANG,Wen SHEN,Su LIU,Zheng-liang MA,Yue SUN,Jing-lang ZHANG,Xiao-hu SU,Shan-shan ZHU,Xue-jun SONG
DOI: https://doi.org/10.3321/j.issn:1001-1978.2009.01.027
2009-01-01
Abstract:Aim: To investigate the effect of intrathecal injection (it) of minocycline (MC), a selective microglia inhibitor, on the maintenance of pain in a murine model of cancer pain. Methods: Forty-two male C3H/He mice were randomly divided into 3 groups (n = 14 each):sham + PBS group was operated and received 10 μl PBS injection into calcaneus medullary space; sarcoma + PBS group and sarcoma + MC group were operated and received 2 × 10 5 sarcoma cells/10 μl PBS implantation into calcaneus medullary space. On the PID11 (post-implantation day 11), 10 mice were taken from each group randomly, sarcoma + PBS group and sham + PBS group were received 0.9% NS (5 μl) it sarcoma + MC group was received MC (1 nmol, 5 μl) it Mechanical pain threshold and cold hyperalgesia assay were measured before and after it at 0.5, 1, 2, 4, 8, 24 It. The last 4 mice of each group were received a normally non-noxious palpation of the ipsilateral heel 90 min on the PID12 after it, then the animals were killed and L 4-6 segment of spinal cord was removed for analysing the c-fos expression (by inummohistochemistry). Results: Bone cancer pain decreased the mechanical and cold pain threshold and activated the c-fos expression in the spinal cord;MC it transient attenuated bone cancer pain-induced hyperalgesia and allodynia and suppressed the expression of c-fos protein. Conclusion: The activation of microglia in the spinal cord may be involved in the maintenance of bone cancer plan.
What problem does this paper attempt to address?